close_game
close_game

Global Chinese Internet giant in talks to lead investment in Gurbaksh Chahal’s RedLotus

Nov 13, 2019 05:17 PM IST

This Chinese firm is among one of the marquee investors in talks to invest in RedLotus, a patented A.I. data platform.

Global entrepreneur, Gurbaksh Chahal previously founded three other highly successful companies that had successful exits. His first Company, ClickAgents sold for $40 million to ValueClick in 2000. BlueLithium was sold to Yahoo for over $300 million in 2007. And, RadiumOne was acquired in 2017 by RhythmOne, a public company on the London Stock Exchange.

Gurbaksh Chahal’s RedLotus headquartered in Hong Kong is tackling a unique problem with data intelligence with the use of A.I. and has attracted quite a few marquee investor interests.
Gurbaksh Chahal’s RedLotus headquartered in Hong Kong is tackling a unique problem with data intelligence with the use of A.I. and has attracted quite a few marquee investor interests.

Now, his current company, RedLotus headquartered in Hong Kong is tackling a unique problem with data intelligence with the use of A.I. and has attracted quite a few marquee investor interests that include a Global Chinese Internet Giant that is looking to lead an investment round, according to a popular tech publication. This institutional round is rumored to be $50 million.

Stay tuned with breaking news on HT Channel on Facebook. Join Now

RedLotus is working on a major pain point for companies to discover predictive customer hero moments. Customer journey analysis is usually studied by companies once the customer completes their decision-making process. However, with RedLotus’ NeuralBank™ patented AI technology, companies can leverage the power of data while the customer is making a decision and intervene through seamless automation. This first-of-its-kind platform empowers companies in the literal sense, where they no longer have to wait to produce personalised results.

The company, Chahal said, has been granted a patent on its AI technology platform NeuralBank and has two patents pending on InfluenceGraph and RM5Studio which enable rapid pattern identification in real time. NeuralBank helps brands automate core marketing decisions using word clouds. InfluenceGraph pulls out consumer influence and sentiment across social media platforms including YouTube and Instagram and uses disparate data on customer sentiment to build a real time profile.

As the growth of online usage surges, the explosion of data continues while decline of the signal to noise ratio accelerates. The growth of social networks as well as emerging 5G and IoT technologies will only result in making data more disparate. RedLotus’ NeuralBank™ patented A.I. technology and patent pending InfluenceGraph™ and RM5 Studio™ deciphers key data signals with rapid pattern identification to automate businesses to achieve desired business outcomes.

“Everything is targeted towards people to buy now. However with sectors like say, auto or food, the transaction doesn’t happen immediately; these are offline. Based on the real time customer profile we have created, we use the data points to target the right fit” he elaborated on how the platform uses real time data. “For example, if a person with modest income is researching a new car online, we target him or her with the entry range of vehicles, followed by financing options. If it is a high income customer, it will be a luxury variant,” he added. RedLotus, employs 100 people, and is already seeing major traction with customers that include Huawei, Microsoft, Volkswagen, IBM, HSBC and Cathay Pacific. The capital will be used for R&D, global expansion with a focus on the Southeast Asian and APAC regions, and acqui-hires. There are also plans to launch in the US later next year.

Disclaimer: This is a company press release. No HT Group journalist is involved in the creation of this content.

SHARE THIS ARTICLE ON
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Sunday, December 10, 2023
Start 14 Days Free Trial Subscribe Now